To provide you with the best possible experience, we use technologies such as cookies to store and/or access device information. If you consent to these technologies, we may process data such as browsing behavior or unique identifiers on this website. If you do not give your consent or withdraw it, certain features and functions may be affected.
Technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service expressly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a message via an electronic communications network.
Technical storage or access is necessary for the legitimate purpose of storing preferences that have not been requested by the subscriber or user.
Technical storage or access carried out solely for statistical purposes.
Technical storage or access used exclusively for anonymous statistical purposes. Without a court order, the voluntary consent of your internet service provider or additional records from third parties, the information stored or accessed for this purpose cannot, as a rule, be used on its own to identify you.
Technical storage or access is required to create user profiles, to send advertising, or to track the user on a website or across multiple websites for similar marketing purposes.
Worldwide unique test for cervical cancer as a gamechanger for the healthcare system
Press ReleasesCancer is and remains one of the greatest health, medical and socio-political challenges of our time. This is also made clear by the World Health Organization’s (WHO) forecast, which predicts […]
Jena Biotechnology Company Files for Insolvency
Press ReleasesJena, Thuringia, March 31, 2025. Jena-based Oncgnostics GmbH has filed for insolvency. The Gera District Court has ordered and appointed lawyer Kai Dellit from the law firm hww hermann wienberg […]
Methylation Tests in Cervical Cancer Screening Could Reduce Invasive Procedures up to 75%
Press ReleasesPorto / Jena, November 26, 2024 – Methylation tests could significantly increase the accuracy of cervical cancer screening and reduce referrals for colposcopy, which would, in turn, put less strain […]
Methylation Testing for Tumor Detection: A Non-Invasive Alternative to Standard Diagnostics
Press ReleasesJena / Düsseldorf, November 7, 2024 – Molecular biological diagnostics offer a non-invasive alternative for cancer detection. oncgnostics GmbH will demonstrate this in Düsseldorf at MEDICA, one of the world’s […]
Oncgnostics expands international distribution
Press ReleasesJena, July 22 – Oncgnostics GmbH signs an agreement with Seegene Germany GmbH for the international distribution of its own tests. Dr. Alfred Hansel, Managing Director of Oncgnostics: “The agreement […]
Psychological stress in cervical cancer tabood
Press ReleasesMedia study: A recent media study by Oncgnostics GmbH shows that, although the general media report on the topic of cervical cancer, they do not address the associated psychological stress […]
Molecular biological cancer diagnostics close gaps in cancer screening
Press ReleasesTwo tests for cervical cancer with different objectives in cervical cancer screening Liquid biopsy for rapid and gentle diagnosis of head and neck tumours Current studies: GynTect DNA methylation test […]
Hong Kong firm invests in Jena-based Oncgnostics GmbH
Press ReleasesJena, September 05, 2023. The Hong Kong-based company Grande Bio-tech Co. Ltd. is making a seven-digit Euros investment in the Jena-based diagnostic company Oncgnostics GmbH. Oncgnostics has developed the cancer […]
Cancer diagnostics of the future thanks to highly informative biomarkers
Press Releasesoncgnostics at Medica 2022: Cervical cancer screening test conquers China Establishing early detection of head and neck tumours First study results for screening test for vulva and vaginal cancer At […]
German oncgnostics GmbH‘s innovation in the area of cervical cancer diagnostics now also available in China
Press ReleasesGynTect receives approval in China Jena, August 25, 2022 – The cervical cancer screening test GynTect is now available to physicians and patients in China, the world’s most populous country. […]